Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$616M |
| 2 |
Netflix
NFLX
|
+$481M |
| 3 |
Micron Technology
MU
|
+$416M |
| 4 |
Tesla
TSLA
|
+$416M |
| 5 |
Procter & Gamble
PG
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$885M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$660M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$463M |
| 4 |
Applovin
APP
|
+$430M |
| 5 |
Meta Platforms (Facebook)
META
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.84% |
| 2 | Healthcare | 15.76% |
| 3 | Consumer Discretionary | 13.86% |
| 4 | Industrials | 9.95% |
| 5 | Financials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2126
Cognition Therapeutics
CGTX
$81.5M
| $1.31M | ﹤0.01% |
969,513
+256,013
| +36% | +$416K |
2023 Q4
8 quarters
|
|
2127
Airgain
AIRG
$53.2M
| $1.31M | ﹤0.01% |
321,636
-58,900
| -15% | -$239K |
2019 Q1
27 quarters
|
|
2128
Sunstone Hotel Investors
SHO
$2.13B
| $1.31M | ﹤0.01% |
+146,052
| New | +$1.34M |
2025 Q4
0 quarters
|
|
2129
CareCloud
CCLD
$82.4M
| $1.3M | ﹤0.01% |
446,030
+218,530
| +96% | +$691K |
2022 Q2
14 quarters
|
|
2130
VersaBank
VBNK
$737M
| $1.3M | ﹤0.01% |
86,900
-4,900
| -5% | -$61.8K |
2023 Q3
9 quarters
|
|
2131
Hawthorn Bancshares
HWBK
$278M
| $1.3M | ﹤0.01% |
37,201
-1,842
| -5% | -$58.9K |
2024 Q1
7 quarters
|
|
2132
iShares MSCI ACWI ex US ETF
ACWX
$17.6B
| $1.3M | ﹤0.01% |
+19,300
| New | +$1.28M |
2025 Q4
0 quarters
|
|
2133
Invesco S&P 500 Pure Value ETF
RPV
$1.66B
| $1.29M | ﹤0.01% |
12,500
-5,400
| -30% | -$544K |
2023 Q4
8 quarters
|
|
2134
Infinity Natural Resources
INR
$252M
| $1.29M | ﹤0.01% |
87,500
+26,100
| +43% | +$342K |
2025 Q1
3 quarters
|
|
2135
Bloomin' Brands
BLMN
$751M
| $1.29M | ﹤0.01% |
+208,854
| New | +$1.46M |
2025 Q4
0 quarters
|
|
2136
Passage Bio
PASG
$14.6M
| $1.29M | ﹤0.01% |
109,089
+8,300
| +8% | +$71.7K |
2021 Q2
18 quarters
|
|
2137
Climb Bio
CLYM
$622M
| $1.28M | ﹤0.01% |
320,600
-216,500
| -40% | -$520K |
2023 Q4
8 quarters
|
|
2138
HBT Financial
HBT
$1.29B
| $1.28M | ﹤0.01% |
49,600
+8,500
| +21% | +$210K |
2024 Q1
7 quarters
|
|
2139
Saga Communications
SGA
$53.1M
| $1.28M | ﹤0.01% |
111,944
-3,900
| -3% | -$47K |
2013 Q2
50 quarters
|
|
2140
Sabra Healthcare REIT
SBRA
$4.9B
| $1.28M | ﹤0.01% |
67,660
-1,036,060
| -94% | -$19.2M |
2023 Q3
9 quarters
|
|
2141
Vanguard Morningstar Mega Cap ETF
MGC
$10.5B
| $1.28M | ﹤0.01% |
5,100
-5,900
| -54% | -$1.47M |
2023 Q2
10 quarters
|
|
2142
Invesco Variable Rate Preferred ETF
VRP
$3B
| $1.28M | ﹤0.01% |
52,578
-213,204
| -80% | -$5.23M |
2022 Q4
12 quarters
|
|
2143
Pliant Therapeutics
PLRX
$61.1M
| $1.28M | ﹤0.01% |
1,045,818
+34,016
| +3% | +$51.1K |
2024 Q1
7 quarters
|
|
2144
Farmland Partners
FPI
$461M
| $1.28M | ﹤0.01% |
131,600
-114,400
| -47% | -$1.15M |
2024 Q4
4 quarters
|
|
2145
Five Star Bancorp
FSBC
$1.05B
| $1.27M | ﹤0.01% |
35,600
-400
| -1% | -$13.9K |
2023 Q1
11 quarters
|
|
2146
Movado Group
MOV
$715M
| $1.27M | ﹤0.01% |
61,698
-6,100
| -9% | -$119K |
2021 Q3
17 quarters
|
|
2147
Vox Royalty Corp
VOXR
$350M
| $1.26M | ﹤0.01% |
266,500
-380,100
| -59% | -$1.72M |
2023 Q1
11 quarters
|
|
|
QIPT
2148
DELISTED
Quipt Home Medical
QIPT
| $1.26M | ﹤0.01% |
357,400
+46,900
| +15% | +$124K |
2023 Q1
11 quarters
|
|
2149
iShares U.S. Thematic Rotation Active ETF
THRO
$7.53B
| $1.26M | ﹤0.01% |
32,700
+16,000
| +96% | +$612K |
2025 Q2
2 quarters
|
|
2150
Helios Technologies
HLIO
$2.27B
| $1.26M | ﹤0.01% |
23,500
-12,500
| -35% | -$674K |
2024 Q4
4 quarters
|
|
Similar funds
Renaissance Technologies's Q4 2025 Portfolio in Review
As of Q4 2025, Renaissance Technologies held 3,923 positions worth $64.5B, down 15% from $75.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $10.1B in Q4 2025, closing 736 positions and reducing 1,682 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $354M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in ServiceNow worth $204M.
- Renaissance Technologies's largest Q4 2025 buy was ServiceNow: 1,331,977 shares worth $204M.
- Renaissance Technologies added most to Costco in Q4 2025, an estimated $616M increase.
- Renaissance Technologies's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $885M.
- Renaissance Technologies fully exited Meta Platforms (Facebook) in Q4 2025, selling an estimated $354M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.5B portfolio in Q4 2025.
- Renaissance Technologies opened 466 new positions and closed 736 in Q4 2025.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $64.5B.
Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.